Final Programme - iuphar
Final Programme - iuphar
Final Programme - iuphar
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
FC08 Developments in the treatment of sexual<br />
dysfunction and diseases of the lower urinary tract<br />
Mon 231 Finasteride and Prazosin mixed therapy in patient with bening prostatic hyperplasia<br />
Seyed Yousef Agha Alaie, (Iran), SS Kashaf, B Najafian, P Musavi<br />
Mon 232 Rho-kinase inhibition impacts neurogenic detrusor overactivity in chronic spinalized rats<br />
Delphine Behr-Roussel, (France), D Broquères-You, S Oger, S Compagnie, A Caisey, P Denys,<br />
E Chartier-Kastler, F Giuliano<br />
Mon 233 Rho-kinase inhibition relaxes detrusor from neurogenic patients<br />
Delphine Behr-Roussel, (France), S Oger, D Gorny, J Bernabé, E Chartier-Kastler, P Denys, F Giuliano<br />
Mon 234 Prevention of urinary tract infections in Norwegian nursing homes<br />
Jenny Bergman, (Norway), H Salvesen Blix, J Schjøtt<br />
Mon 235 Innervated myofibroblasts in the urinary bladder? Functional and ultrastructural evidence<br />
Elizabeth Burcher, (Australia), P Sadananda, S Sandow<br />
Mon 236 Comparison of central nervous system penetration of antimuscarinic drugs for overactive bladder<br />
E Callegari, R Webster, K Fenner, J LaPerle, B Malhotra, Peter Bungay (USA)<br />
Mon 237 Role of rasayan herbs on reproductive parameters of male rats<br />
Nagendra Chauhan, (India), VK Dixit<br />
Mon 238 Fractionation of saw palmetto extracts and bioassay fractions in isolated rat prostate<br />
Thiam Chua, (Australia), J Simpson, S Ventura<br />
Mon 239 Vascular insulin resistance in penile arteries from a rat model of metabolic syndrome<br />
C Contreras, A Sánchez, B Climent, A García-Sacristán, S Benedito, Dolores Prieto, (Spain)<br />
Mon 240 Role of CX43 in the maintenance of spontaneous activity in the guinea pig prostate<br />
Anupa Dey, (Australia), S Kusljic, RJ Lang, B Exintaris<br />
Mon 241 Developments in the treatment of sexual dysfunction and diseases of the lower urinary tract<br />
Saintmoses Eromosele, (Nigeria), V Eruanga, PA Francis<br />
Mon 242 Pacemaker cells and contractility in the prostate gland<br />
Betty Exintaris, (Australia), A Dey, S Kusljic, M Lam, D-T Nguyen, R Lang<br />
Mon 243 Hydrogen sulfide promotes function of T-type calcium channels and secretion of prostatic acid<br />
phosphatase in neuroendocrine-like prostate cancer cells from the androgen-sensitive LNCaP cell line<br />
Kazuki Fukami, (Japan), R Kasamatsu, S Yoshida, F Sekiguchi, A Kawabata<br />
Mon 244 Effects of duloxetine on bladder and external urethral sphincter in anesthetized female guinea-pigs with<br />
intravesical acetic acid<br />
Véronique Guilloteau, (France), S Palea, M Guerard, T Westfall, P Lluel<br />
Mon 245 On pharmaco-toxicological approaches to vesical dysfunction<br />
Ulrich Härlin, (Germany), E Neu, A Hofstetter, G Staehler, S Magour, G Ernst, W Seidenbusch,<br />
MC Michailov, D Hüting, U Welscher, J Foltinova<br />
Mon 246 To investigate the effects of 5-HT and electrical field stimulation (EFS) in the bladder of Suncus murinus<br />
Farideh A Javid, (UK)<br />
Mon 247 Effects of potassium channel openers on parameters of ureteral function – an in vivo animal study<br />
Carsten Krahtz, (Germany), AJ Becker, ME Mayer, MA Kuczyk, CG Stief<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 179
Change language